Efficacy and safety of perioperative dose-dense chemotherapy for breast cancer patients, including elderly population

被引：0
|
作者：
Ishiguro, Atsushi [1 ]
Tanimoto, Aya [1 ]
Ito, Keiichiro [1 ]
Ohigashi, An [1 ]
机构：
[1] Teine Keijinkai Hosp, Dept Med Oncol, Sapporo, Hokkaido, Japan
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.588
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO11-1
引用
收藏
页码：S303 / S303
页数：1
相关论文
共 50 条
  • [31] The relevance of macrocytosis induction during neoadjuvant dose-dense chemotherapy in breast cancer patients
    Jelavic, Tihana Boraska
    Podrug, Mario
    Ban, Marija
    Lovasic, Ingrid Belac
    Curic, Zvonimir
    Vrdoljak, Eduard
    ANTI-CANCER DRUGS, 2022, 33 (01) : E655 - E661
  • [32] Impact of dose-dense chemotherapy on the immune system of earlys breast cancer (EBC) patients
    Rovati, B.
    Collova, E.
    Grasso, D.
    Ferrari, S.
    Manzoni, M.
    Bencardino, K.
    Danova, M.
    CYTOMETRY PART A, 2006, 69A (05) : 474 - 474
  • [33] Safety and efficacy outcomes for patients ages 65 and older treated with dose-dense chemotherapy for epithelial ovarian cancer.
    Teplinsky, Eleonora
    Caldwell, Haven Lindsay
    Kohn, Nina
    Cheng, Kit
    Hoffman, Mark Allan
    Dos Santos, Lisa A.
    Sakaris, Antoinette
    Shih, Karin
    Lovecchio, John L.
    Whyte, Jill Suzanne
    Menzin, Andrew
    John, Veena S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [34] Lymphopenia in dose-dense chemotherapy for early stage breast cancer.
    Tolaney, S. M.
    Partridge, A. H.
    Scheib, R. G.
    Ligibel, J. A.
    Shulman, L. N.
    Winer, E. P.
    Burstein, H. J.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S112 - S112
  • [35] HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients
    L Del Mastro
    P Bruzzi
    G Nicolò
    G Cavazzini
    A Contu
    M D'Amico
    A Lavarello
    F Testore
    B Castagneto
    E Aitini
    L Perdelli
    C Bighin
    R Rosso
    Marco Venturini
    British Journal of Cancer, 2005, 93 : 7 - 14
  • [36] Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer
    Razis, E
    Dimopoulus, AM
    Bafaloukos, D
    Papadimitriou, C
    Kalogera-Fountzila, A
    Kalofonos, H
    Briassoulis, E
    Samantas, E
    Keramopoulos, A
    Pavlidis, N
    Kosmidis, P
    Fountzilas, G
    CANCER INVESTIGATION, 2001, 19 (02) : 137 - 144
  • [37] CHEMOTHERAPY Dose-dense treatment for triple-negative breast cancer
    Amir, Eitan
    Ocana, Alberto
    Freedman, Orit
    Clemons, Mark
    Seruga, Bostjan
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (02) : 79 - 80
  • [38] Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer
    Tolaney, Sara M.
    Partridge, Ann H.
    Sheib, Rochelle G.
    Burstein, Harold J.
    Winer, Eric P.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (33) : 5330 - 5331
  • [39] HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients
    Del Mastro, L
    Bruzzi, P
    Nicolò, G
    Cavazzini, G
    Contu, A
    D'Amico, M
    Lavarello, A
    Testore, F
    Castagneto, B
    Aitini, E
    Perdelli, L
    Bighin, C
    Rosso, R
    Venturini, M
    BRITISH JOURNAL OF CANCER, 2005, 93 (01) : 7 - 14
  • [40] Maternal and Neonatal Outcomes of Dose-Dense Chemotherapy for Breast Cancer in Pregnancy
    Cardonick, Elyce
    Gilmandyar, Dzhamala
    Somer, Robert A.
    OBSTETRICS AND GYNECOLOGY, 2012, 120 (06): : 1267 - 1272
12345